NCT00583375

Brief Summary

STUDY OBJECTIVES: Demonstrate equivalent clinical and radiologic outcomes to the "gold standard" (ABG) in a representative clinical model (hindfoot and ankle fusions) STUDY HYPOTHESIS: Augment® Bone Graft is an equivalent bone grafting substitute to autologous bone graft in applications as shown by non-inferiority analysis STUDY RATIONALE: Evaluate a fully synthetic growth-factor enhanced bone graft substitute to facilitate fusion in conditions or injuries requiring bone graft in a representative clinical fusion model and thus the opportunity to provide equivalent union rates as ABG without necessitating an additional invasive procedure to harvest the graft REGULATORY PHASE: Investigational Device Exemption (IDE) for Premarket Approval (PMA) Application as a bone regeneration system, pivotal phase

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
414

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2007

Typical duration for not_applicable

Geographic Reach
2 countries

37 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2007

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 20, 2007

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 31, 2007

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2010

Completed
8.1 years until next milestone

Results Posted

Study results publicly available

February 23, 2018

Completed
Last Updated

April 2, 2018

Status Verified

March 1, 2018

Enrollment Period

2.8 years

First QC Date

December 20, 2007

Results QC Date

November 7, 2017

Last Update Submit

March 6, 2018

Conditions

Keywords

arthritisankle painfoot painhindfoot fractureankle fracture

Outcome Measures

Primary Outcomes (1)

  • Subjects Fused at 24 Weeks (as Determined by CT Assessment)

    An independent radiologist examined CT images for all patients' joints and determined whether or not the joint had at least 50% osseous bridging. If a patient demonstrated all joints having at least 50% osseous bridging, this patient was classified as fused.

    24 weeks

Secondary Outcomes (5)

  • Pain on Weight Bearing

    24 and 52 Weeks

  • Pain at Fusion Site

    24 and 52 weeks

  • Foot Function Index (FFI)

    24 and 52 weeks

  • AOFAS Hindfoot and Ankle Score

    24 and 52 weeks

  • SF-12 Physical Component Score

    24 and 52 weeks

Study Arms (2)

Group 1

ACTIVE COMPARATOR

Standard Rigid Fixation plus autograft Standard of Care: Autologous Bone Graft

Procedure: Standard of Care

Group 2

EXPERIMENTAL

Standard Rigid Fixation plus Augment® Bone Graft

Device: Augment® Bone Graft

Interventions

Augment® Bone Graft

Group 2

Autologous Bone Graft

Group 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \) Bone defect in the hindfoot or ankle requiring fusion using open surgical technique with supplemental bone graft/substitute, requiring one of the following procedures:
  • Ankle joint fusion
  • Subtalar fusion
  • Calcaneocuboid fusion
  • Talonavicular fusion
  • Triple arthrodesis (subtalar, talonavicular and calcaneocuboid joints)
  • Double fusions (talonavicular and calcaneocuboid joints)

You may not qualify if:

  • Previous fusion surgery of the proposed fusion site.
  • The patient uses chronic medications known to affect the skeleton (e.g. glucocorticoid usage \> 10mg/day).
  • Pregnant or a female intending to become pregnant during this study period.
  • Morbidly obese (BMI \> 45 kg/m2)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (37)

Tucson Orthopaedic Institute

Tucson, Arizona, 85712, United States

Location

California Pacific Orthopaedics & Sports Medicine

San Francisco, California, 94118, United States

Location

Santa Cruz Orthopaedic Institute

Santa Cruz, California, 95065, United States

Location

Hartford Hospital Orthopaedic Center

Hartford, Connecticut, 06106, United States

Location

The Center for Bone & Joint Surgery

Royal Palm Beach, Florida, 33411, United States

Location

Southern Orthopaedic Center

Savannah, Georgia, 31405, United States

Location

Illinois Bone and Joint Institute, Ltd.

Glenview, Illinois, 60025, United States

Location

Loyola University Medical Center

Maywood, Illinois, 60153, United States

Location

SIU School of Medicine

Springfield, Illinois, 62794, United States

Location

Advanced Orthopaedic Associates

Wichita, Kansas, 67226, United States

Location

Union Memorial Hospital

Baltimore, Maryland, 21218, United States

Location

Mid Michigan Orthopaedic Institute

East Lansing, Michigan, 48823, United States

Location

Orthopaedic Associates of Grand Rapids

Grand Rapids, Michigan, 49525, United States

Location

Henry Ford Hospital - West Bloomfield

West Bloomfield, Michigan, 48322, United States

Location

Desert Orthopaedic Center

Las Vegas, Nevada, 89121, United States

Location

UMDNJ

Newark, New Jersey, 07103, United States

Location

Hospital for Special Surgery

New York, New York, 10021, United States

Location

Columbia University Medical Center

New York, New York, 10032, United States

Location

University of Rochester Medical Center

Rochester, New York, 14627, United States

Location

Ortho Carolina Research Institute

Charlotte, North Carolina, 28209, United States

Location

Duke Health Center

Durham, North Carolina, 27704, United States

Location

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Orthopedic Foot & Ankle Center

Columbus, Ohio, 43231, United States

Location

Orthopaedic & Neurosurgical Care & Research

Bend, Oregon, 97701, United States

Location

The Rothman Institute

Philadelphia, Pennsylvania, 19107, United States

Location

University Orthopaedics, Inc

Providence, Rhode Island, 02905, United States

Location

Campbell Clinic

Germantown, Tennessee, 38138, United States

Location

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

Bone and Joint Clinic of Houston

Houston, Texas, 77030, United States

Location

The Orthopaedic Foot and Ankle Center

Arlington, Virginia, 22206, United States

Location

Marshfield Clinic

Marshfield, Wisconsin, 54449, United States

Location

Peter Lougheed Centre

Calgary, Alberta, T1Y 6H6, Canada

Location

St. Paul's Hospital

Vancouver, British Columbia, V6Z 1Y6, Canada

Location

Queen Elizabeth II Health Sciences Center

Halifax, Nova Scotia, B3H 3A7, Canada

Location

The Ottawa Hospital, General Campus

Ottawa, Ontario, K1H 8L6, Canada

Location

St. Michael's Hospital

Toronto, Ontario, M5C 1R6, Canada

Location

University Health Network

Toronto, Ontario, M5T 2S8, Canada

Location

MeSH Terms

Conditions

ArthritisAnkle Fractures

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesFractures, BoneWounds and InjuriesAnkle InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
Stephen Roach
Organization
Wright Medical

Study Officials

  • Christopher DiGiovanni, M.D.

    Rhode Island Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2007

First Posted

December 31, 2007

Study Start

April 1, 2007

Primary Completion

January 1, 2010

Study Completion

February 1, 2010

Last Updated

April 2, 2018

Results First Posted

February 23, 2018

Record last verified: 2018-03

Locations